Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Management of Moderate Coronary Atherosclerosis

Risk Classification and Significance

  • A coronary artery calcium score (CACS) of 171 indicates moderate coronary atherosclerosis, requiring aggressive risk factor modification, including moderate-intensity statin therapy, lifestyle changes, and comprehensive cardiovascular risk management, as recommended by the American College of Cardiology and the American Heart Association 1, 2
  • A CACS of 171 falls into the moderate CAC category (101-400), indicating definite atherosclerotic plaque burden and increased risk for future cardiovascular events, with a 3.8 times higher risk for myocardial infarction compared to those with CACS of zero 1, 3, 4
  • This score represents approximately 20% of the total atherosclerosis burden, as not all plaques contain calcium, and suggests the patient's arterial age is significantly higher than their chronological age 1, 3

Primary Prevention Recommendations

  • The American College of Cardiology recommends moderate to high-intensity statin therapy as the cornerstone of management for CACS >100, with a demonstrated 22% relative risk reduction in major cardiovascular events in clinical trials 2, 5
  • Lifestyle modifications, including regular physical activity (150 minutes of moderate-intensity exercise weekly), a heart-healthy diet (Mediterranean or DASH diet), smoking cessation, and weight management, are recommended to reduce cardiovascular risk 1, 2

Additional Risk Factor Management

  • The American Heart Association recommends targeting blood pressure control <130/80 mmHg for most patients, and lipid management beyond statins, aiming for LDL-C reduction based on overall risk profile 2, 6
  • Antiplatelet therapy, such as low-dose aspirin, should be considered in selected patients after weighing bleeding risk against cardiovascular benefit, and diabetes management should optimize glycemic control if present 2, 5

Follow-up Recommendations

  • Regular cardiovascular risk assessment should be performed annually, and medication adherence monitoring should be done regularly to ensure compliance with statin therapy, as recommended by the American College of Cardiology 6
  • If a follow-up scan is considered, it should not be performed sooner than 3-5 years, and further cardiac testing should be considered if the patient develops symptoms of coronary artery disease 6, 7, 8

Important Considerations and Pitfalls

  • The CACS of 171 indicates definite atherosclerosis and should not be dismissed, even if traditional risk calculators suggest low risk, and the location of calcium deposits affects risk stratification, with left main coronary artery calcification carrying higher risk 1, 3, 6
  • CACS indicates atherosclerosis burden but does not necessarily correlate with degree of stenosis, and should be interpreted in the context of other risk factors and not in isolation 1, 2, 8

Risk Reclassification

  • A CACS of 171 may reclassify a patient from low or intermediate risk to high risk, regardless of traditional risk factors, providing confidence that the patient will have event rates that exceed benefit thresholds (≥7.5% in 10 years) for preventive interventions, as recommended by the American College of Cardiology 1, 2, 5

REFERENCES

6

Management of Coronary Artery Calcium Score [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025